NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I believe that $5 billion would be a fair and reasonable price at this time for 25% of the company. Of course new stock would need to be authorized, but lets get the TLD and Journal out, and that shouldn't be a problem.

Here's what IMGN just released on their Soraya trial:
https://newsfilter.io/a/fb50af581c53b9603d98c9bbea295b4e

With the announcement of positive trial results they're committing to having the BLA out this month, and will PR that event as well.

I'm hoping we get a similar declaration when our TLD and Journal are out, pledging to have the BLA out within a month, even two or three months would be quite positive. Depending on when we get the TLD and Journal having one or more approvals this year is far from being out of the realm of possibilities.

As an IMGN investor, I'm happy with their news, but I believe the potential of DCVax-L to be 10 to 100 times or more greater than the IMGN product if some other solid cancers are determined to benefit from our vaccine. IMGN's product may well be a blockbuster product in time, but ours will be many times that on GBM alone.

Gary